1392116-84-5

Basic information

• Product Name: tert-butoxy[4-(4-methoxy-3,5-dimethylphenyl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]acetic acid
• Synonyms: tert-butoxy[4-(4-methoxy-3,5-dimethylphenyl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]acetic acid
• CAS NO: 1392116-84-5
• Molecular Weight: 423.509
• Mol File: 1392116-84-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butoxy[4-(4-methoxy-3,5-dimethylphenyl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butoxy[4-(4-methoxy-3,5-dimethylphenyl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]acetic acid(1392116-84-5)
• EPA Substance Registry System: tert-butoxy[4-(4-methoxy-3,5-dimethylphenyl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]acetic acid(1392116-84-5)

Safety Data

• Hazardous Substances Data: 1392116-84-5(Hazardous Substances Data)

Upstream product

• 1392119-05-9 tert-butoxy[4-(4-methoxy-3,5-dimethylphenyl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]acetic acid methyl ester 
• 1392119-04-8 (4-bromo-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl)-2-(tert-butoxy)acetic acid methyl ester 
• 1392119-02-6 (4-bromo-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl)hydroxyacetic acid methyl ester 
• 1392119-00-4 (4-bromo-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl)-2-[(trimethylsilanyl)oxy]acetonitrile 
• 1392118-99-8 4-bromo-2-methyl-1-oxo-1,2-dihydroisoquinoline-3-carbaldehyde 
• 1392118-97-6 4-bromo-3-(hydroxymethyl)-2-methylisoquinolin-1(2H)-one 
• 1392118-95-4 4-bromo-3-(tert-butyldimethylsilanyloxymethyl)-2-methyl-2H-isoquinolin-1-one 
• 1392118-93-2 4-bromo-3-(((tert-butyldimethylsilyl)oxy)methyl)isoquinolin-1(2H)-one 
• 1392118-92-1 4-bromo-3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-isochromen-1-one 
• 610-97-9 o-iodo-methyl-benzoic acid 
• 103606-72-0 methyl 2-(3-hydroxyprop-1-yn-1-yl)benzoate 

Relevant articles and documents

ISOQUINOLINE COMPOUNDS AND METHODS FOR TREATING HIV

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).